You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
上實城市開發(00563.HK)附屬向關連方提供項目管理服務 涉管理費2,000萬人幣
阿思達克 11-20 09:33
上實城市開發(00563.HK)公布關連交易,公司之全資附屬上實城開上海建設與上海上藥生物醫藥訂立項目管理服務協議,上實城開上海建設同意就項目向對方提供項目管理服務,管理費總額為2,000萬元人民幣。

上海上藥生物醫藥為項目之開發商,項目位於上海市浦東新區張江路92號,總建築面積約為12.6萬平方米。

上海上藥生物醫藥為上海醫藥集團之全資附屬,而上海醫藥集團則為上海上實之非全資附屬。公司控股股東上實集團為對上海上實行使國有股東權利之獲授權代表。因此,上海上藥生物醫藥為上實集團之聯繫人及公司之關連人士。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account